Estia Health (ASX:EHE) has announced its Board has approved an on-market share buy-back of up to 10% of its issued capital over the next 12 months, to be managed within the '10/12' limit permitted by the Corporations Act 2001 (Cth).
The buy-back will take into account the prevailing share price, market conditions and any incremental capital requirements.
Estia Health says no shareholder approval is required.